Clinical Trial Update: Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome [NA]

View source ↗

Summary

A clinical trial comparing pulmonary compliance between Curosurf and Survanta in preterm infants with Respiratory Distress Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Curosurf (poractant alfa)
• SURVANTA (beractant)

Snippet

Sponsor: University of Michigan | Conditions: Respiratory Distress Syndrome | NA | Status: WITHDRAWN